| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |